These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3056443)

  • 1. Diagnostic uses of angiotensin-converting enzyme inhibitors in renovascular hypertension.
    Wilcox CS; Williams CM; Smith TB; Frederickson ED; Wingo C; Bucci CM
    Am J Hypertens; 1988 Oct; 1(4 Pt 2):344S-349S. PubMed ID: 3056443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of converting enzyme inhibitors in diagnosis of renovascular hypertension. I. Comparison of the effect of angiotensin converting enzyme inhibition on blood pressure and plasma renin activity in patients with primary hypertension and renovascular hypertension].
    Posadzy-Małaczyńska A
    Przegl Lek; 1997; 54(5):314-9. PubMed ID: 9380805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional testing: renin studies.
    Wilcox CS
    Semin Nephrol; 2000 Sep; 20(5):432-6. PubMed ID: 11022895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of angiotensin converting enzyme inhibitors in the diagnosis of renovascular hypertension. II. Comparison of the effect of angiotensin converting enzyme inhibition on reno-scintigraphic curves with DTPA in patients with essential and renovascular hypertension].
    Posadzy-Małaczyńska A
    Przegl Lek; 1997; 54(7-8):524-8. PubMed ID: 9480462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of angiotensin converting enzyme inhibitors in the diagnosis of renovascular hypertension. III. Evaluation of the validity of the captopril test and the reno-scintigraphic captopril test in the diagnosis of renovascular hypertension according to accepted criteria].
    Posadzy-Małaczyńska A
    Przegl Lek; 1997; 54(9):591-6. PubMed ID: 9501677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of the captopril test for identifying correctable unilateral renovascular hypertension.
    Kutkuhn B; Godehardt E; Kunert J; Torsello G; Grabensee B
    Clin Exp Hypertens A; 1991; 13(2):143-57. PubMed ID: 2065461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renovascular hypertension in blacks.
    Emovon OE; Klotman PE; Dunnick NR; Kadir S; Svetkey LP
    Am J Hypertens; 1996 Jan; 9(1):18-23. PubMed ID: 8834702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renovascular hypertension. New diagnostic and therapeutic procedures.
    Jensen G
    Scand J Urol Nephrol Suppl; 1995; 170():1-78. PubMed ID: 7667614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Captopril test and renal duplex scanning for the primary screening of renovascular disease.
    Miralles M; Covas MI; Martínez Miralles E; Cairols M; Cotillas J; Santiso MA
    Am J Hypertens; 1997 Nov; 10(11):1290-6. PubMed ID: 9397249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The captopril tests: a new concept in detecting renovascular hypertension?
    Nally JV
    Cleve Clin J Med; 1989 Jun; 56(4):395-401. PubMed ID: 2663228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two noninvasive screening tests for renovascular hypertension.
    Elliott WJ; Martin WB; Murphy MB
    Arch Intern Med; 1993 Mar; 153(6):755-64. PubMed ID: 8447713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation between renovascular and essential hypertension by means of changes in single kidney 99mTc-DTPA clearance induced by angiotensin-converting enzyme inhibition.
    Pedersen EB; Jensen FT; Eiskjaer H; Hansen HH; Jensen JD; Jespersen B; Madsen B; Nielsen HK; Sørensen SS
    Am J Hypertens; 1989 May; 2(5 Pt 1):323-34. PubMed ID: 2655658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Converting enzyme inhibitors in the diagnosis of secondary arterial hypertension --focus on the captopril test].
    Pêco M
    Rev Port Cardiol; 2000 Dec; 19 Suppl 2():II35-41. PubMed ID: 11301909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of converting enzyme inhibitors on split renal function in renovascular hypertension.
    Miyamori I; Yasuhara S; Takeda R
    Clin Exp Hypertens A; 1987; 9(2-3):629-32. PubMed ID: 3038426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of the captopril test and the effect of captopril on renal function.
    Lu ZW; Liu LS
    J Hum Hypertens; 1990 Apr; 4(2):138-40. PubMed ID: 2187090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute blockage of the renin system and differential renal vein renin determinations in the diagnosis of renovascular hypertension.
    Kutkuhn B; Godehardt E; Kunert J; Torsello G; Grabensee B
    Scand J Urol Nephrol; 1996 Feb; 30(1):69-72. PubMed ID: 8727869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Captopril renography in the diagnosis of renovascular hypertension].
    Jensen JJ; Møller ML; Lund JO; Trap-Jensen J
    Ugeskr Laeger; 1991 Jun; 153(23):1648-51. PubMed ID: 2058027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril renal scintigraphy in renovascular hypertension.
    Khairullah QT; Somers DL; Aktay R
    Am Fam Physician; 1997 May; 55(6):2240-4. PubMed ID: 9149651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitor-enhanced MR renography: repeated measures of GFR and RPF in hypertensive patients.
    Zhang JL; Rusinek H; Bokacheva L; Lim RP; Chen Q; Storey P; Prince K; Hecht EM; Kim DC; Lee VS
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F884-91. PubMed ID: 19158343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension.
    Ideishi M; Sasaguri M; Ikeda M; Arakawa K
    Clin Ther; 1989; 11(4):441-51. PubMed ID: 2550133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.